TRSG vs ZGM
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
TRSG presents a dichotomy between a stable balance sheet and a failing market trajectory. The Piotroski F-Score of 5/9 indicates stable financial health, supported by a very low Debt/Equity ratio (0.17) and strong liquidity (Current Ratio 2.26). However, the stock is trading significantly above its growth-based intrinsic value ($0.35) and slightly above its Graham Number ($1.14), while suffering from a catastrophic 5-year price decline of 79.5%. While revenue growth is strong at 37%, it lags behind the sector average, and the technical trend remains entirely bearish.
ZGM presents a contradictory profile: it possesses a stable Piotroski F-Score of 5/9 and an exceptionally clean balance sheet, yet it is plagued by severe growth decay. With revenue down 27% and earnings plummeting 78% YoY, the company's operational trajectory is sharply negative. The stock is currently trading at a significant premium to both its Graham Number ($1.16) and Intrinsic Value ($0.70), suggesting a lack of fundamental support for the current price. Despite high profit margins, the combination of collapsing growth and bearish technicals makes this a high-risk asset.
Compare Another Pair
Related Comparisons
TRSG vs ZGM: Head-to-Head Comparison
This page compares Tungray Technologies Inc. (TRSG) and Zenta Group Co Ltd (ZGM) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.